Key points are not available for this paper at this time.
A simple 6 variable clinical score may be used to guide use of PYP and increase recognition of ATTR-CM among patients with HFpEF in the community. Further validation in larger and more diverse populations is needed.
Davies et al. (2022) studied this question.